UBS Raises Price Target on AMN Healthcare Services (AHS) to $48.50; Reiterates Buy
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
AMN Healthcare Services (AHS) Tops Q2 EPS by 8c; Guides Q3 Revenue
August 4, 2016 4:24 PM EDTAMN Healthcare Services (NYSE: AHS) reported Q2 EPS of $0.61, $0.08 better than the analyst estimate of $0.53. Revenue for the quarter came in at $473.7 million versus the consensus estimate of $455.14 million.
GUIDANCE:
AMN Healthcare Services sees Q3 2016 revenue of $466-472 million, versus the... More
Trading Radar for 8/4: Kellogg (K), MGM Resorts (MGM), Activision (ATVI), FireEye (FEYE), Weight Watchers (WTW) Report
August 3, 2016 2:51 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
AAC Holdings (NYSE: AAC) - consensus EPS $0.23
AGCO Corp. (Nasdaq: AGCO) - consensus EPS $0.92
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.77
Acceleron Pharma (NYSE: XLRN) - consensus loss $0.50
Agios Pharma (Nasdaq:... More